权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Nudging people with Type 2 diabetes towards sustained adherence to self-management: a cluster randomized controlled trial

推动 2 型糖尿病患者持续坚持自我管理：一项整群随机对照试验

基本信息

批准号：
20K18934
负责人：
Rouyard Thomas
金额：
$ 2.58万
依托单位：
Hitotsubashi University
依托单位国家：
日本
项目类别：
Grant-in-Aid for Early-Career Scientists
财政年份：
2020
资助国家：
日本
起止时间：
2020-04-01 至 2024-03-31
项目状态：
已结题

项目摘要

- The study aims to evaluate the effects of a personalized behavioral intervention (‘FEEDBACK’) developed to improve self-management behavior in adults with type 2 diabetes. FEEDBACK is a resource-minimizing intervention designed to be delivered by general practitioners (GPs) in routine primary care settings. The study is a cluster randomized controlled trial (RCT) with six months follow-up.- In Japan, where the implementation of primary care policy has just begun, it is necessary to introduce evidence-based, person-centered diabetic care into the practice of GPs nationwide. If we could link our FEEDBACK intervention with improved patient outcomes and delivery in primary care, this would provide further justification for stronger primary care services and investment in primary care in Japan.2022:- After numerous study implementation challenges and delays encountered in 2020 and 2021 due to the COVID-19 pandemic, we have now managed to make good progress in the recruitment process. Eighteen GP practices have been recruited so far, which is close to our initial sample size objective (n=20). We would like to recruit a few more practices to ensure that our pre-registered minimum effect size of interest can be detectable.- As we made good process on the recruitment process, we submitted the study protocol for publication in an international peer-reviewed journal in January 2023. The manuscript has been accepted for publication in the journal 'Trials'.

- 该研究旨在评估个性化行为干预（“反馈”）的效果，以改善2型糖尿病成人的自我管理行为。反馈是一种资源最小化的干预措施，旨在由全科医生（GP）在常规初级保健环境中提供。该研究是一项为期6个月的随机对照试验（RCT）。在日本，初级保健政策的实施刚刚开始，有必要在全国范围内的全科医生实践中引入以证据为基础的、以人为本的糖尿病护理。2022年：-在2020年及2021年因COVID-19大流行而遭遇众多研究实施挑战及延误后，我们现已设法在招募过程中取得良好进展。到目前为止，已招募了18名全科医生，这接近我们最初的样本量目标（n=20）。我们想招募更多的实践，以确保我们的预注册的最小效应大小可以检测到。由于我们在招募过程中取得了良好的进展，我们于2023年1月提交了研究方案，以在国际同行评审期刊上发表。该手稿已被《审判》杂志接受发表。